Discovery of Biomarkers for Endometrial Carcinoma

From LEAP

Revision as of 16:21, 9 June 2009 by Bpeat (Talk | contribs)
Jump to: navigation, search

Purpose: Discovering biomarkers for endometrial carcinoma rapidly by direct profiling of proteins in tissue sections.
Methods: nano-scale MALDI-Spotting and MALDI QqTOF mass spectrometry.
Results: Five up-regulated protein markers for endometrial carcinoma were discovered with the new tool.

image:Workflow1.png

Discovery of Biomarkers for Endometrial Carcinoma by Direct Profiling of Proteins in Tissue Sections Using Selective MALDI-SPOTTING and MALDI MS

Jingzhong Guo (1); Muntajib Alhaq (2); Leroi V. DeSouza (1); Gordon Nye (3); Werner Martin (3); Alexander D. Romaschin (4); Terence J. Colgan (2); K..W. Michael Siu (1) 1 York University, Toronto, ON, Canada; 2 Mount Sinai Hospital, Toronto, ON, Canada; 3 LEAP Technologies, Inc., Carrboro, NC; 4 Toronto General Hospital, Toronto, ON, Canada


Reprint of Article

ASMS 2005 Poster - Discovery of Biomarkers for Endometrial Carcinoma by Direct Profiling of Proteins in Tissue Sections Using Selective MALDI-Spotting and MALDI MS


Contact LEAP

For additional information about this technique please contact LEAP Technologies for detailed information

Contact the LEAP office

Personal tools